Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
adaptavir (1 trial)
Communicable Diseases (Phase 2)
HIV Infections (Phase 2)
Infections (Phase 2)
Trials (1 total)
Trial APIs (1 total)